# Safety and Effectiveness Study of Perceval S Valve for Extended CE Mark

Study · id `cardio:ct-nct01368666` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01368666](<https://clinicaltrials.gov/study/NCT01368666>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01368666

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 658 participants.

## Technical summary

Registry record NCT01368666. Allocation not applicable; no masking; primary purpose treatment. Start 2010-02-23 (actual); primary completion 2014-10-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 658 participants (enrolled count; ClinicalTrials.gov record NCT01368666, source copy `cardio:ctgov-nct01368666-2024-03-06`, retrieved 2026-10-26)
- Started: 2010-02-23 (actual) (ClinicalTrials.gov record NCT01368666, source copy `cardio:ctgov-nct01368666-2024-03-06`, retrieved 2026-10-26)
- Primary completion: 2014-10-31 (actual) (ClinicalTrials.gov record NCT01368666, source copy `cardio:ctgov-nct01368666-2024-03-06`, retrieved 2026-10-26)
- Completion: 2020-01-31 (actual) (ClinicalTrials.gov record NCT01368666, source copy `cardio:ctgov-nct01368666-2024-03-06`, retrieved 2026-10-26)
- Countries: Austria; Belgium; France; Germany; Netherlands; Poland; Switzerland; United Kingdom (ClinicalTrials.gov record NCT01368666, source copy `cardio:ctgov-nct01368666-2024-03-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01368666-2024-03-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Effectiveness Study of Perceval S Valve for Extended CE Mark
- Acronym: CAVALIER
- Condition: Aortic Valve Replacement
- Intervention (Device): Perceval S Valve Prosthesis
- Lead sponsor: Corcym S.r.l
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

## Provenance

Content hash: 7753e754ded89bc600ddc84a1871983d20bc3bae6aeaf7ac426478a8f888ba40
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
